Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone — surpassing 45 million users worldwide,
Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone — surpassing 45 million users worldwide,
Bitget Celebrates Its 6th Anniversary, Surpassing 45 Million Users
VICTORIA, Seychelles, Sept. 20, 2024 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly celebrates its 6th anniversary with a significant milestone — surpassing 45 million users worldwide,
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of